Establishment of human cancer cell clones with different characteristics: A model for screening chemopreventive agents

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 1-16

  Ware, Jeffrey H ^a   Zhou, Zhaozong ^a   Guan, Jun ^a   Kennedy, Ann R ^a   Kopelovich, Levy ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Human cancer cell clones; Limiting dilution; Parental population

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CELL CLONE; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; CULTURE TECHNIQUE; DRUG SCREENING; HUMAN; HUMAN CELL; LUNG CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CLONE CELLS; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR STEM CELLS; URINARY BLADDER NEOPLASMS;

EID: 33847678123     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Rhim JS and Kung H-F: Human prostate carcinogenesis. Critical Rev. Oncogen 8: 305-328, 1997.
2. Wan XS et al: Establishment and characterization of sublines of LNCaP human prostate cancer cells. Oncol Rep 10: 1569-1575, 2003.
3. Keepers YP et al: Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 27: 897-900, 1991.
4. Freshney RI: Culture of Animal Cells. Vol. 2nd Edition. New York: Alan R. Liss, Inc., pp. 137-153, 1987.
5. Nawata H et al: Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture. J Biol Chem 256: 6895-6902, 1981.
6. Soule HD et al: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416, 1973.
7. Gierthy JF et al: Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J Cell Biochem 45: 177-187, 1991.
8. Pourreau-Schneider N et al: How culture conditions modulate the morphofunctional differentiation of the human estradiol-sensitive mammary cell line (MCF-7). J Ster Biochem 20: 407-415, 1984.
9. Sonnenschein C, Papendorp JT and Soto AM: Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF-7 human breast tumor cells. Life Sciences 37: 387-394, 1985.
10. Sawatsri S et al: Inhibition of estrogen-dependent breast cell responses with phenylacetate. Inter J Cancer 93: 687-692, 2001.
11. Beckmann MW et al: Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays. Europ J Cancer 28: 322-326, 1992.
12. Reddel RR, Murphy LC and Sutherland RL: Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res 44: 2398-2405, 1984.
13. Kaighn ME et al: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
14. Stone KR et al: Isolation of a human prostate carcinoma cell line (DU 145). Intl J Cancer 21: 274-281, 1978.
15. Liu AY: Expression of CD44 in prostate cancer cells. Cancer Lett 76: 63-69, 1994.
16. Janssen T et al: Influence of dihydrotestosterone, epidermal growth factor, and basic fibroblast growth factor on the cell kinetics of the PC3, DU145, and LNCaP prostatic cancer cell lines: relationship with DNA ploidy level. Prostate 27: 277-286, 1995.
17. Horoszewicz JS et al: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
18. Wan XS et al: Treatment with the soybean-derived Bowman Birk Inhibitor increases the serum prostate specific antigen concentration while suppressing the growth of human prostate cancer xenografts in nude mice. Prostate 41: 243-252, 1999.
19. Rajagopal S et al: Modulation of cellular proliferation and production of prostate-specific antigen and matrix adhesion molecules in human prostate carcinoma cells by polypeptide growth factors: comparative analyses of MDA PCa2a with established cell lines. Intl J Oncol 12: 589-595, 1998.
20. Tilley WD et al: Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res 50: 5382-5386, 1990.
21. Giard DJ et al: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
22. Brattain MG et al: Heterogeneity of malignant cells from a human colonie carcinoma. Cancer Research 41: 1751-1756, 1981.
23. Campbell SE et al: Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines. BMC Cancer 6: 13, 2006.
24. Nayak SK, O'Toole C and Price ZH: A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. British Journal of Cancer 35: 142-151, 1977.
25. Bubenik J et al: Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. International Journal of Cancer 11: 765-773, 1973.
26. Freedman VH and Shin S: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359, 1974.
27. Gleave ME et al: Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147: 1151-1159, 1992.
28. Zhang Y et al: Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res. 62: 1205-1212, 2002.
29. Zhang, HJ et al: Comparison of effects of two polymorphic variants of manganese superoxide dismutase on human breast MCF-7 cancer cell phenotype. Cancer Res 59: 6276-6283, 1999.
30. Johnson TL and Moyer MP: Normal human colon cells suppress malignancy when fused with colon cancer cells. In Vitro Cell Develop Biol 26: 1095-1100, 1990.
31. Li JJ et al: Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10: 1989-2000, 1995.
32. Han YL et al: Studies on the phenotype deviation of the single-cell subclones of human stomach carcinoma MGC-803 cell line. Shih Yen Sheng Wu Hsueh Pao. J Exp Biol 29: 13-23, 1996 in Chinese.
33. Christensen B, Kieler J and Bem W: Growth requirements and growth pattern of human urothelial cell lines of different grades of transformation. Anticancer Res 7: 481-490, 1987.
34. Hebert CD, Cao QL and Birnbaum LS: Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD). Carcinogenesis 11: 1335-1342, 1990.
35. Reese DH et al: Effect of retinoic acid on the growth and morphology of a prostatic adenocarcinoma cell line cloned for the retinoid inducibility of alkaline phosphatase. Cancer Res 43: 5443-5450, 1983.
36. Nakshatri H et al: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639, 1997.
37. Muir CS and Black RJ: Time trends in hormone-dependent cancer. Progr Clin Biol Res 394: 25-40, 1996.
38. Stephenson RA et al: Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J. Natl. Cancer Inst 84: 951-957, 1992.
39. Pflug BR, Reiter RE and Nelson JB: Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines. Prostate 40: 269-273, 1999.
40. Tso CL et al: Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J 6: 220-233, 2000.
41. Iizumi T et al: Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 137: 1304-1306, 1987.
42. Polin L et al: Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice. Investigat. New Drugs 15: 99-108, 1997.
43. Barrett JC: Cell culture models of multistep carcinogenesis. IARC Sci. Publications 58: 181-202, 1985.
44. Freedman DA and Navidi WC: Multistage models for carcinogenesis. Environ Health Persp 81: 169-188, 1989.
45. Cook P, Doll R and Fellingham SA: A mathematical model for the age distribution of cancer in man. Intl J Cancer 4: 93-112, 1969.
46. Manton KG and Stallard E: Bioactuarial models of national mortality time series data. Hlth Care Fin Rev 3: 89-106, 1982.
47. Manton KG, Malker H and Malker B: A comparison of temporal changes in U.S. and Swedish lung cancer, 1950-51 to 1981-82. J Natl Cancer Inst 77: 665-675, 1986.
48. Moolgavkar SH: A population perspective on multistage carcinogenesis. Princess Takamatsu Symposia 22: 381-391, 1991
49. Moolgavkar SH and Luebeck EG: Multistage carcinogenesis: population-based model for colon cancer. J Natl Cancer Inst 84: 610-618, 1992.
50. Thompson TC et al: Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell 56: 917-930, 1989.
51. Weiss KM: Cancer models and cancer genetics. Epidemiol 1: 486-490, 1990.
52. Lockhart DJ and Winzeler EA: Genomics, gene expression and DNA arrays. Nature 405: 827-836, 2000.
53. Duggan DJ et al: Expression profiling using cDNA microarrays. Nature Genetics 21(1 Suppl): 10-14, 1999.